{"id":"W3150954884","doi":"10.1007/s12185-021-03126-6","title":"Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia","year":2021,"lang":"en","type":"review","venue":"International Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Druggability; Tyrosine kinase; Tyrosine-kinase inhibitor; Dasatinib; Homoharringtonine; Oncology; Hematology; Pharmacology; Adverse effect; Chronic myelogenous leukemia; Cancer research; Leukemia; Cancer; Internal medicine; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004824182,0.0007325735,0.001711145,0.001583616,0.0001797724,0.0009253862,0.0008295635,0.0007673791,0.003379635],"category_scores_gemma":[0.000668609,0.0002385308,0.0007047192,0.001649809,0.0002479647,0.0008579824,0.0004295144,0.002091452,0.001360017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004078287,"about_ca_system_score_gemma":0.0006300284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008704608,"about_ca_topic_score_gemma":0.002100683,"domain_scores_codex":[0.9998499,0.000022916,0.0000243494,0.000025273,0.00006159137,0.00001599343],"domain_scores_gemma":[0.9997577,0.0001130388,0.00005176302,0.000005257718,0.00005310477,0.0000191291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001738519,0.00009886229,0.0001364285,0.01561697,0.000176453,0.0001094034,0.0000240809,0.0005124568,0.001452127,0.001751127,0.01987778,0.9600705],"study_design_scores_gemma":[0.0001639683,0.0004478898,0.00152254,0.006944799,0.0007434803,0.001298639,0.0000408545,0.0003123261,0.0008623643,0.001526526,0.9861053,0.00003130691],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000112625,0.9989391,0.00008584284,0.0001345788,0.0001095582,0.000005074956,0.00002376093,0.000006219288,0.0005832488],"genre_scores_gemma":[0.0007140206,0.9984351,0.0001522346,0.0001914235,0.00009758979,0.0000055793,0.0000354912,9.354362e-7,0.0003676901],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003379635,"threshold_uncertainty_score":0.01130605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0223135065839013,"score_gpt":0.3286523114547571,"score_spread":0.3063388048708558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}